Pictet Asset Management (Switzerland)’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	$13M	Sell	601,646 -832,200	-58%	-$18M	0.02%	567
2023 Q1	$42.1M	Buy	1,433,846 +312,081	+28%	+$9.16M	0.05%	313
2022 Q4	$41.4M	Buy	+1,121,765	New	+$41.4M	0.06%	308